MAPK3 and glioblastoma: Altogether, these results suggest that PBA downregulates mutp53 and activates wtp53 both in wt and mutp53-carrying cells and that such effects correlated with the reduced expression of MVK of the mevalonate pathway and ERK1/2-reduced phosphorylation in glioblastoma cells.